These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 10777704)

  • 61. PPAR(gamma)2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population.
    Yamamoto Y; Hirose H; Miyashita K; Nishikai K; Saito I; Taniyama M; Tomita M; Saruta T
    Metabolism; 2002 Nov; 51(11):1407-9. PubMed ID: 12404189
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women.
    Valve R; Sivenius K; Miettinen R; Pihlajamäki J; Rissanen A; Deeb SS; Auwerx J; Uusitupa M; Laakso M
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3708-12. PubMed ID: 10523018
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population.
    González Sánchez JL; Serrano Ríos M; Fernández Perez C; Laakso M; Martínez Larrad MT
    Eur J Endocrinol; 2002 Oct; 147(4):495-501. PubMed ID: 12370112
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relationship between PPARγ Pro12Ala gene polymorphism and type 2 diabetic nephropathy risk in Asian population: results from a meta-analysis.
    Liu G; Zhou TB; Jiang Z; Zheng D; Yuan F; Li Y; Hu H; Chen Z
    J Recept Signal Transduct Res; 2014 Apr; 34(2):131-6. PubMed ID: 24303936
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth.
    Eriksson JG; Lindi V; Uusitupa M; Forsén TJ; Laakso M; Osmond C; Barker DJ
    Diabetes; 2002 Jul; 51(7):2321-4. PubMed ID: 12086968
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.
    Mancini FP; Vaccaro O; Sabatino L; Tufano A; Rivellese AA; Riccardi G; Colantuoni V
    Diabetes; 1999 Jul; 48(7):1466-8. PubMed ID: 10389855
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes.
    Clement K; Hercberg S; Passinge B; Galan P; Varroud-Vial M; Shuldiner AR; Beamer BA; Charpentier G; Guy-Grand B; Froguel P; Vaisse C
    Int J Obes Relat Metab Disord; 2000 Mar; 24(3):391-3. PubMed ID: 10757637
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Pro12Ala PPARgamma2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men.
    Rosmond R; Chagnon M; Bouchard C
    Diabetes Metab Res Rev; 2003; 19(2):159-63. PubMed ID: 12673785
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.
    Swarbrick MM; Chapman CM; McQuillan BM; Hung J; Thompson PL; Beilby JP
    Eur J Endocrinol; 2001 Mar; 144(3):277-82. PubMed ID: 11248748
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: thrifty genotype, thrifty phenotype, or both?
    Poulsen P; Andersen G; Fenger M; Hansen T; Echwald SM; Vølund A; Beck-Nielsen H; Pedersen O; Vaag A
    Diabetes; 2003 Jan; 52(1):194-8. PubMed ID: 12502512
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma is associated with increased leptin levels in women with type-2 diabetes mellitus.
    Simón I; Vendrell J; Gutiérrez C; Fernández-Real JM; Vendrell I; Gallart L; Fontova R; Richart C
    Horm Res; 2002; 58(3):143-9. PubMed ID: 12218380
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Polymorphism of Pro12Ala in the peroxisome proliferator-activated receptor gamma2 gene in Iranian diabetic and obese subjects.
    Mirzaei H; Akrami SM; Golmohammadi T; Doosti M; Heshmat R; Nakhjavani M; Amiri P
    Metab Syndr Relat Disord; 2009 Oct; 7(5):453-8. PubMed ID: 19558269
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?
    Franks PW; Luan J; Browne PO; Harding AH; O'Rahilly S; Chatterjee VK; Wareham NJ
    Metabolism; 2004 Jan; 53(1):11-6. PubMed ID: 14681835
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis.
    Temelkova-Kurktschiev T; Hanefeld M; Chinetti G; Zawadzki C; Haulon S; Kubaszek A; Koehler C; Leonhardt W; Staels B; Laakso M
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4238-42. PubMed ID: 15356014
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association between Pro12Ala polymorphism and albuminuria in type 2 diabetic nephropathy.
    Chen YN; Wang PW; Tung SC; Kuo MC; Weng SW; Chou CK; Chang CM; Tsa CJ; Taso CF; Shen FC; Chen JF
    J Diabetes Investig; 2020 Jul; 11(4):923-929. PubMed ID: 31912623
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Frequency and significance of Pro12Ala and Pro115Gln polymorphism in gene for peroxisome proliferation-activated receptor-gamma regarding metabolic parameters in a Caucasian cohort.
    Schäffler A; Barth N; Schmitz G; Zietz B; Palitzsch KD; Schölmerich J
    Endocrine; 2001 Apr; 14(3):369-73. PubMed ID: 11444435
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [PPARgamma antagonist as a potential drug for the treatment of obesity and diabetes].
    Waki H; Yamauchi T; Kadowaki T
    Nihon Rinsho; 2010 Feb; 68(2):350-5. PubMed ID: 20158108
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Influence of polymorphism pro12Ala of PPARgamma gene on endothelium destruction in patients with diabetes mellitus t. 2].
    Gacka M; Dobosz T; Szymaniec S; Bednarska-Chabowska D; Adamiec R
    Pol Arch Med Wewn; 2005 Nov; 114(5):1055-65. PubMed ID: 16789503
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study.
    Li S; Chen W; Srinivasan SR; Boerwinkle E; Berenson GS;
    Diabetes; 2003 May; 52(5):1265-9. PubMed ID: 12716762
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene is not associated with postprandial responses to glucose or fat tolerance tests in young healthy subjects: the European Atherosclerosis Research Study II.
    Poirier O; Nicaud V; Cambien F; Tiret L
    J Mol Med (Berl); 2000; 78(6):346-51. PubMed ID: 11001532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.